BioPharma M&A: Keys to Success

WATCH THIS PROGRAM ON-DEMAND / CLICK HERE TO REGISTER TO VIEW THE PROGRAM

Expert Webcast BioPharma M&A

Over the first half of 2019, a staggering $170B has been pledged to biopharma buyout activities, an amount that exceeds the total deal spend of the last three years combined. With the increasing complexity and frequency of biopharma M&A transactions, how do you ensure that synergy targets are met or exceeded? What are some of the key success factors, and what are some of the biggest ‘real-world’ pitfalls and watch-outs to address? In this panel we will be exploring these topics with highly experienced “roll-up-the sleeves” executives who have succeeded in M&A where others have failed. Please send your questions in advance, as this engaging talk promises to offer tangible lessons learned and takeaways. In this panel we will be exploring these topics with highly experienced “roll-up-the sleeves” executives who have succeeded in M&A where others have failed. Please send your questions in advance, as this engaging talk promises to offer tangible lessons learned and takeaways.

SPEAKERS:

Kate Hardey, Partner, McGuireWoods

Alex Zisson, Managing Director, HIG Capital

Zeid Barakat, Senior Director, Scimitar Inc.

Richard Andersen, Founder and CEO, ShareVault

MODERATOR:

Alex Kasdan, Senior Managing Director, DelMorgan & Co.

LEADING FIRMS SHARE THEIR KNOWLEDGE ON EXPERT WEBCAST:

About the Author
Expert Webcast is a sophisticated digital source of expertise for the professional and the business communities locally, nationally and cross-border. Producing the industry’s leading webcast panels covering corporate, M&A, restructuring and finance topics, Expert Webcast addresses timely and relevant issues faced by business owners, C-level executives, corporate advisers and institutional investors.